Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Ethinyl estradiol; norgestrel - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for ethinyl estradiol; norgestrel?

Ethinyl estradiol; norgestrel is the generic ingredient in eleven branded drugs marketed by Wyeth Pharms, Novast Labs Ltd, Watson Labs, Pelagius, Mylan Labs Ltd, Duramed Pharms Barr, and Mayne Pharma, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norgestrel. Eight suppliers are listed for this compound.

Summary for Generic Name: ethinyl estradiol; norgestrel

Tradenames:11
Patents:1
Applicants:7
NDAs:9
Drug Master File Entries: see list26
Suppliers / Packagers: see list8
Clinical Trials: see list260
Drug Prices:see low prices
DailyMed Link:ethinyl estradiol; norgestrel at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
OGESTREL 0.5/50-28
ethinyl estradiol; norgestrel
TABLET;ORAL-28075406-002Dec 15, 1999RXNoYes► Subscribe► Subscribe
Watson Labs
OGESTREL 0.5/50-21
ethinyl estradiol; norgestrel
TABLET;ORAL-21075406-001Dec 15, 1999DISCNNoNo► Subscribe► Subscribe
Mayne Pharma
LOW-OGESTREL-21
ethinyl estradiol; norgestrel
TABLET;ORAL-21075288-001Jul 28, 1999DISCNNoNo► Subscribe► Subscribe
Wyeth Pharms
LO/OVRAL-28
ethinyl estradiol; norgestrel
TABLET;ORAL-28017802-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Duramed Pharms Barr
CRYSELLE
ethinyl estradiol; norgestrel
TABLET;ORAL-21075840-001Nov 30, 2001RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ethinyl estradiol; norgestrel

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pelagius
LO/OVRAL
ethinyl estradiol; norgestrel
TABLET;ORAL-21017612-001Approved Prior to Jan 1, 19823,850,911► Subscribe
Wyeth Pharms
OVRAL
ethinyl estradiol; norgestrel
TABLET;ORAL-21016672-001Approved Prior to Jan 1, 19823,666,858► Subscribe
Wyeth Pharms
OVRAL-28
ethinyl estradiol; norgestrel
TABLET;ORAL-28016806-001Approved Prior to Jan 1, 19823,850,911► Subscribe
Wyeth Pharms
OVRAL-28
ethinyl estradiol; norgestrel
TABLET;ORAL-28016806-001Approved Prior to Jan 1, 19823,959,322► Subscribe
Wyeth Pharms
LO/OVRAL-28
ethinyl estradiol; norgestrel
TABLET;ORAL-28017802-001Approved Prior to Jan 1, 19823,959,322► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc